{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:11:47Z","timestamp":1790719907889,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.contraception.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T23:48:26Z","timestamp":1347839306000},"page":"319-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Contraception technology: past, present and future"],"prefix":"10.1016","volume":"87","author":[{"given":"Regine","family":"Sitruk-Ware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Daniel R.","family":"Mishell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.08.002_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2010.08.015","article-title":"New strategies for providing hormonal contraception in developing countries","volume":"83","author":"Townsend","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0010","series-title":"Eunice Kennedy Shriver National Institute of Child Health and Human Development, January 25\u201326, Bethesda, Maryland","article-title":"Scientific vision workshop on reproduction, workshop white paper","author":"Giudice","year":"2011"},{"key":"10.1016\/j.contraception.2012.08.002_bb0015","series-title":"World contraceptive use 2007 [wall chart]","author":"United Nations (UN)","year":"2008"},{"key":"10.1016\/j.contraception.2012.08.002_bb0020","first-page":"1","article-title":"Transitions in world population","author":"Population Reference Bureau Staff","year":"2004","journal-title":"Popul Bull"},{"key":"10.1016\/j.contraception.2012.08.002_bb0025","series-title":"World population data sheet of the Population Reference Bureau","first-page":"1","year":"2004"},{"key":"10.1016\/j.contraception.2012.08.002_bb0030","series-title":"Promises to keep: the toll of unintended pregnancies on women's lives in the developing world","author":"Daulaire","year":"2002"},{"key":"10.1016\/j.contraception.2012.08.002_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2008.06.001","article-title":"The potential of long-acting reversible contraception to decrease unintended pregnancy","volume":"78","author":"Speidel","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in rates of unintended pregnancy in the United States, 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.08.002_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1363\/4307811","article-title":"Unintended pregnancy rates at the state level","volume":"43","author":"Finer","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.08.002_bb0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxq012","article-title":"Family planning and the burden of unintended pregnancies","volume":"32","author":"Tsui","year":"2010","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.contraception.2012.08.002_bb0055","series-title":"Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000","author":"World Health Organization (WHO)","year":"2004"},{"key":"10.1016\/j.contraception.2012.08.002_bb0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1363\/4009408","article-title":"Factors associated with contraceptive choice and inconsistent method use, United States, 2004","volume":"40","author":"Frost","year":"2008","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.08.002_bb0065","first-page":"1","article-title":"Improving contraceptive use in the United States","author":"Frost","year":"2008","journal-title":"Issues Brief (Alan Guttmacher Inst)"},{"key":"10.1016\/j.contraception.2012.08.002_bb0070","first-page":"95","article-title":"Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth","volume":"23","author":"Chandra","year":"2005","journal-title":"Natl Cent Health Stat"},{"key":"10.1016\/j.contraception.2012.08.002_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2007.09.013","article-title":"Estimates of contraceptive failure from the 2002 National Survey of Family Growth","volume":"77","author":"Kost","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2005.08.019","article-title":"Contraception: an international perspective","volume":"73","author":"Sitruk-Ware","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0039-128X(00)00126-4","article-title":"The return of the pharmaceutical industry to the market of contraception","volume":"65","author":"Johansson","year":"2000","journal-title":"Steroids"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.08.002_bb0090","first-page":"7","article-title":"Oral contraception: past, present, and future perspectives","volume":"36","author":"Mishell","year":"1991","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2012.08.002_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.08.002_bb0100","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.08.002_bb0105","first-page":"i77","article-title":"Oral comparative effects of a four-phasic regimen of estradiol valerate\/dienogest versus ethinylestradiol\/levonorgestrel on haemostatic parameters","volume":"23","author":"Parke","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/13625187.2011.604450","article-title":"Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism","volume":"16","author":"\u00c5gren","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.08.002_bb0115","article-title":"Synergistic effect of 17-\u03b2estradiol and nomegestrol acetate used in a new monophasic oral contraceptive","author":"Chabbert-Buffet","year":"2009"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2012.08.002_bb0120","first-page":"17","article-title":"Estetrol: a new estrogen in the pill?","volume":"13","author":"Visser","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.08.002_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2012.08.002_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2005-864035","article-title":"Progesterone receptor antagonists and the endometrial antiproliferative effect","volume":"23","author":"Brenner","year":"2005","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.contraception.2012.08.002_bb0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.002_bb0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.08.002_bb0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2011.10.003","article-title":"Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women","volume":"85","author":"Brache","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0010-7824(92)90101-X","article-title":"Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control, and lipid profiles","volume":"46","author":"Alvarez-Sanchez","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.contraception.2012.08.002_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyloestradiol","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 \u03bcg ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(97)00008-5","article-title":"Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(99)00057-8","article-title":"Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women","volume":"60","author":"Massai","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0180","first-page":"11","article-title":"Mechanism of action of progesterone as contraceptive for lactating women. Annals New York Academy of Sciences. Part II","volume":"626","author":"Diaz","year":"1991","journal-title":"Contracept Steril"},{"key":"10.1016\/j.contraception.2012.08.002_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2006.12.003","article-title":"Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives","volume":"75","author":"Wan","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0195","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.002_bb0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration","volume":"62","author":"De Lignieres","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.002_bb0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0210","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.08.002_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13625180400008940","article-title":"Combined ethinylestradiol\/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers","volume":"9","author":"Heger-Mahn","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.08.002_bb0225","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajog.2011.06.055","article-title":"The future of contraception: innovations in contraceptive agents: tomorrow's hormonal contraceptive agents and their clinical implications","volume":"205","author":"Jensen","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0230","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.contraception.2011.10.006","article-title":"Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial","volume":"85","author":"Archer","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0235","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0039-128X(03)00140-5","article-title":"Nestorone: clinical applications for contraception and HRT","volume":"68","author":"Sitruk-Ware","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2012.08.002_bb0240","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2007.08.006","article-title":"An initial pharmacokinetic study with Metered Dose Transdermal System for delivery of the progestogen Nestorone as a possible future contraceptive","volume":"76","author":"Fraser","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0245","article-title":"Ulipristal blocks ovulation by inhibiting progesterone Receptor-dependent pathways intrinsic to the ovary","author":"Nallasamy","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.contraception.2012.08.002_bb0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2007.04.005","article-title":"Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for \u201cdual protection\u201d emergency contraception","volume":"76","author":"Brache","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0255","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajog.2007.10.787","article-title":"Contraceptive efficacy of intrauterine devices","volume":"198","author":"Thonneau","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajog.2003.07.021","article-title":"Pregnancy during the use of levonorgestrel intrauterine system","volume":"190","author":"Backman","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/ebm1168","article-title":"Hysterectomy, endometrial destruction and the levonorgestrel intrauterine system are all effective therapies for heavy menstrual bleeding; satisfaction rates are highest after hysterectomy","volume":"16","author":"Fraser","year":"2011","journal-title":"Evid Based Med"},{"key":"10.1016\/j.contraception.2012.08.002_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0412.2011.01303.x","article-title":"Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS)","volume":"91","author":"Heikinheimo","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2012.08.002_bb0275","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, Phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.08.002_bb0280","unstructured":"A study of a levonorgestrel-releasing intrauterine system for long-term, reversible contraception. Available on http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00995150?term=intrauterine+system&rank=3. Last accessed on 10\/31\/11."},{"key":"10.1016\/j.contraception.2012.08.002_bb0285","unstructured":"An explorative trial to explore the safety, acceptability and vaginal bleeding pattern of three etonogestrel-releasing medicated intrauterine systems. Available on http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00967746?term=intrauterine+system&rank=9. Last accessed on 10\/31\/11."},{"key":"10.1016\/j.contraception.2012.08.002_bb0290","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.contraception.2009.11.004","article-title":"Intrauterine administration of CDB-2914 (ulipristal) suppresses the endometrium of rhesus macaques","volume":"81","author":"Brenner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0295","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0039-128X(03)00120-X","article-title":"A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists","volume":"68","author":"Brenner","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2012.08.002_bb0300","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1021\/jm001000c","article-title":"Synthesis and biologic activity of a novel, highly potent progesterone receptor antagonist","volume":"43","author":"Fuhrmann","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.contraception.2012.08.002_bb0305","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/humrep\/dem235","article-title":"Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study","volume":"22","author":"Heikinheimo","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0310","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0010-7824(01)00188-3","article-title":"Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health","volume":"63","year":"2001","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2012.08.002_bb0315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience","volume":"13","author":"Graesslin","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.08.002_bb0320","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0010-7824(01)00259-1","article-title":"Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women","volume":"64","author":"Massai","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0325","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.contraception.2003.10.003","article-title":"Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women","volume":"69","author":"Sivin","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0010-7824(95)00263-4","article-title":"Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant","volume":"53","author":"Coutinho","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2011.07.014","article-title":"Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate","volume":"25","author":"Pitts","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2012.08.002_bb0340","first-page":"CD005214","article-title":"Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception","volume":"19","author":"Draper","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.08.002_bb0345","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0350","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2012.08.002_bb0355","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9378(85)90664-7","article-title":"Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol","volume":"151","author":"Goebelsmann","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0360","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1479-828X.1991.tb02769.x","article-title":"Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust N Z J ObstetGynaecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0365","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0370","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0b013e3181a1d3ce","article-title":"Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis","volume":"113","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.AOG.0000165826.03915.65","article-title":"Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial","volume":"106","author":"Davis","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0380","first-page":"489","article-title":"Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents","volume":"30","author":"Aslam","year":"2010","journal-title":"J ObstetGynaecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0385","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial","volume":"83","author":"Shabaan","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0390","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.08.002_bb0395","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.contraception.2012.08.002_bb0400","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","article-title":"Oral contraceptive use and risk of hip fracture: a case\u2013control study","volume":"353","author":"Michaelsson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.08.002_bb0405","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/152.3.242","article-title":"Oral contraceptive and benign ovarian tumors","volume":"152","author":"Westhoff","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0410","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ajog.2011.06.056","article-title":"The state of hormonal contraception today: established and emerging noncontraceptive health benefit","volume":"205","author":"Maguire","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0415","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/1940-6207.CAPR-10-0244","article-title":"Aa progesterone receptorptosis","volume":"4","author":"Wiehle","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.contraception.2012.08.002_bb0420","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1210\/en.2010-0005","article-title":"Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo","volume":"151","author":"Liu","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.08.002_bb0425","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1210\/en.2011-1219","article-title":"Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors","volume":"152","author":"Hussain","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.08.002_bb0430","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.AOG.0000278078.45640.13","article-title":"Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial","volume":"110","author":"Barnhart","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0435","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/AOG.0b013e3181644598","article-title":"Noncomparative contraceptive efficacy of cellulose sulfate gel","volume":"111","author":"Mauck","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0440","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/AOG.0b013e3181fc3b1a","article-title":"Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial","volume":"116","author":"Burke","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.qai.0000159671.25950.74","article-title":"In vitro and in vivo: the story of nonoxynol 9","volume":"39","author":"Hillier","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2012.08.002_bb0450","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.contraception.2008.04.118","article-title":"SILCS diaphragm: postcoital testing of a new single-size contraceptive device","volume":"78","author":"Schwartz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.08.002_bb0455","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/humrep\/dep392","article-title":"Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception","volume":"25","author":"Jesam","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0460","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/16.7.1323","article-title":"Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study","volume":"16","author":"Pall","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0465","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/sj.emboj.7601431","article-title":"Protein kinase B\/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation","volume":"25","author":"Han","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.contraception.2012.08.002_bb0470","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1095\/biolreprod.109.081984","article-title":"WEE2 is an oocyte-specific meiosis inhibitor in Rhesus macaque monkeys","volume":"82","author":"Hanna","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0475","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1095\/biolreprod.110.084418","article-title":"Cumulus\u2013oocyte complexes from small antral follicles during the early follicular phase of menstrual cycles in rhesus monkeys yield oocytes that reinitiate meiosis and fertilize in vitro","volume":"83","author":"Peluffo","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0480","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.1171396","article-title":"MAPK3\/1 (ERK1\/2) in ovarian granulosa cells are essential for female fertility","volume":"324","author":"Fan","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.contraception.2012.08.002_bb0485","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1095\/biolreprod.103.016022","article-title":"Zygote arrest 1 (Zar1) is an evolutionarily conserved gene expressed in vertebrate ovaries","volume":"69","author":"Wu","year":"2003","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2012.08.002_bb0490","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.2010.05688.x","article-title":"The future of women's contraception: stakes and modalities","volume":"1205","author":"Hugon-Rodin","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.contraception.2012.08.002_bb0495","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1210\/er.2002-0002","article-title":"Male contraception","volume":"23","author":"Anderson","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.contraception.2012.08.002_bb0500","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MOU.0b013e32833f1b4a","article-title":"Hormonal approaches to male contraception","volume":"20","author":"Wang","year":"2010","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.contraception.2012.08.002_bb0505","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1210\/endo.130.6.1597164","article-title":"The biological activity of 7a-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone","volume":"130","author":"Kumar","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.contraception.2012.08.002_bb0510","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-1384","article-title":"New combination of testosterone and nestorone transdermal gels for male hormonal contraception","author":"Ilani","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.002_bb0515","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2008-2604","article-title":"Combined transdermal testosterone gel and the progestin Nestorone suppresses serum gonadotropins in men","volume":"94","author":"Mahabadi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.002_bb0520","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1210\/jc.2008-0265","article-title":"Male hormonal contraception: a double-blind, placebo-controlled study","volume":"93","author":"Mommers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2012.08.002_bb0525","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0039-128X(03)00135-1","article-title":"Use of progestins in male contraception","volume":"68","author":"Nieschlag","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2012.08.002_bb0530","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/spmg.1.4.18393","article-title":"Adjudin disrupts spermatogenesis via the action of some unlikely partners: Eps8, Arp2\/3 complex, drebrin E, PAR6 and 14-3-3","volume":"1","author":"Cheng","year":"2011","journal-title":"Spermatogenesis"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412007299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412007299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:01Z","timestamp":1761432241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412007299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0010782412007299"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.08.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception technology: past, present and future","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}